We are live on ! Find out more
AZN icon

AstraZeneca
AZN

981 hedge funds and large institutions have $34.2B invested in AstraZeneca in 2022 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 340 increasing their positions, 299 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 79

31% more funds holding in top 10

Funds holding in top 10: 13 → 17 (+4)

17% more capital invested

Capital invested by funds: $29.4B → $34.2B (+$4.85B)

14% more repeat investments, than reductions

Existing positions increased: 340 | Existing positions reduced: 299

3% more funds holding

Funds holding: 949 → 981 (+32)

10% more call options, than puts

Call options by funds: $495M | Put options by funds: $450M

0.4% more ownership

Funds ownership: 16.27% → 16.67% (+0.4%)

Holders
981
Holders Change
+32
Holders Change %
+3.37%
% of All Funds
15.47%
Holding in Top 10
17
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+30.77%
% of All Funds
0.27%
New
120
Increased
340
Reduced
299
Closed
79
Calls
$495M
Puts
$450M
Net Calls
+$44.6M
Net Calls Change
-$159M

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$317M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$263M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$197M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$149M
5
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$128M

Top Sellers

1
HSBC Holdings
HSBC Holdings
United Kingdom
-$414M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$150M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$81.8M
4
Renaissance Technologies
Renaissance Technologies
New York
-$75.4M
5
Legal & General Group
Legal & General Group
United Kingdom
-$73.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
SW
351
SVB Wealth
Massachusetts
$1.19M -$853K -7,115 -44%
SWP
352
Stratos Wealth Partners
Ohio
$1.19M -$11.8K -98 -1%
OC
353
Oarsman Capital
Wisconsin
$1.18M +$37.4K +312 +4%
CCA
354
Checchi Capital Advisers
California
$1.17M +$39.2K +327 +4%
MCM
355
Mitchell Capital Management
Kansas
$1.17M +$57.9K +483 +6%
Citadel Advisors
356
Citadel Advisors
Florida
$1.16M -$69.5M -579,477 -99%
Nisa Investment Advisors
357
Nisa Investment Advisors
Missouri
$1.16M +$1.05M +8,731 New
PTC
358
Private Trust Company
Ohio
$1.15M -$806K -6,717 -44%
Nomura Asset Management
359
Nomura Asset Management
Japan
$1.15M +$1.04M +8,644 New
FFA
360
Fragasso Financial Advisors
Pennsylvania
$1.14M +$2.64K +22 +0.3%
WFI
361
West Family Investments
California
$1.14M +$33.1K +276 +3%
TAIM
362
TD Ameritrade Investment Management
Nebraska
$1.13M +$17.5K +146 +2%
S
363
SimplyRich
California
$1.12M – – –
Barclays
364
Barclays
United Kingdom
$1.12M -$24.1M -201,308 -96%
SFA
365
Sequoia Financial Advisors
Ohio
$1.11M +$286K +2,381 +39%
DBG
366
De Burlo Group
Massachusetts
$1.11M – – –
CIC
367
Carnegie Investment Counsel
Ohio
$1.11M -$65.8K -549 -6%
CWM
368
CIBC World Markets
New York
$1.09M +$990K +8,257 New
WT
369
Whittier Trust
California
$1.09M +$460K +3,836 +88%
Prudential Financial
370
Prudential Financial
New Jersey
$1.08M +$37.2K +310 +4%
PWPS
371
Pinnacle Wealth Planning Services
Ohio
$1.08M +$21.1K +176 +2%
AWM
372
AE Wealth Management
Kansas
$1.06M -$1.65M -13,746 -63%
SWM
373
SeaCrest Wealth Management
New York
$1.06M +$115K +957 +14%
RC
374
RegentAtlantic Capital
New Jersey
$1.05M +$1.68K +14 +0.2%
CSS
375
Cubist Systematic Strategies
Connecticut
$1.05M +$39.9K +333 +4%
13 14
15
16 17

AZN Hedge Fund Activity: Q1 2022 in Review

981 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q1 2022, worth a combined $34.2B — up 17% from $29.4B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new AZN positions and 79 closed out — a net gain of 41 holders — while 340 added to existing stakes and 299 trimmed.

The largest buyer was Franklin Resources, adding an estimated $317M. The largest seller was HSBC Holdings, cutting an estimated $414M.

  • 981 institutional investors held AstraZeneca (AZN) as of Q1 2022, up from 949 in Q4 2021.
  • Funds reported $34.2B of AstraZeneca stock for Q1 2022, up 17% quarter-over-quarter.
  • 120 funds opened new AstraZeneca positions in Q1 2022 and 79 closed out, a net change of +41 holders.
  • The largest AstraZeneca buyer in Q1 2022 was Franklin Resources, an estimated $317M added.
  • The largest AstraZeneca seller in Q1 2022 was HSBC Holdings, an estimated $414M sold.

Based on aggregated 13F filings for Q1 2022.